Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients

被引：0
|
作者：
Matson, Vyara [1 ]
Fessler, Jessica [1 ]
Bao, Riyue [1 ]
Chongsuwat, Tara [1 ]
Zha, Yuanyuan [1 ]
Alegre, Maria-Luisa [1 ]
Luke, Jason [1 ]
Gajewski, Thomas [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P394
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma reply
    da Silva, Ines Pires
    Ahmed, Tasnia
    Reijers, Irene L. M.
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Allayous, Clara
    Mangana, Joanna
    Zimmer, Lisa
    Trojaniello, Claudia
    Klein, Oliver
    Gerard, Camille L.
    Michielin, Olivier
    Haydon, Andrew
    Ascierto, Paolo A.
    Carlino, Matteo S.
    Lebbe, Celeste
    Lorigan, Paul
    Johnson, Douglas B.
    Sandhu, Shahneen
    Lo, Serigne N.
    Menzies, Alexander M.
    Long, Georgina, V
    LANCET ONCOLOGY, 2021, 22 (08): : E343 - E344
  • [42] Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
    Hugo, Willy
    Zaretsky, Jesse M.
    Sun, Lu
    Song, Chunying
    Moreno, Blanca Homet
    Hu-Lieskovan, Siwen
    Berent-Maoz, Beata
    Pang, Jia
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Lomeli, Shirley
    Kong, Xiangju
    Kelley, Mark C.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Ribas, Antoni
    Lo, Roger S.
    CELL, 2016, 165 (01) : 35 - 44
  • [43] Fecal microbiota transplantation combined with anti-PD-1 inhibitor for unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor.
    Park, Sook Ryun
    Kim, Gihyeon
    Kim, Yunjae
    Cho, Beomki
    Kim, Sang-Yeob
    Do, Eun-Ju
    Bae, Dong-Jun
    Kweon, Mi-Na
    Song, Joon Seon
    Park, Hansoo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy
    Martinovic, Katarina Mirjacic
    Vuletic, Ana
    Miletic, Nevena Tisma
    Matkovic, Suzana
    Gavrilovic, Dusica
    Ninkovic, Aleksandra
    Jurisic, Vladimir
    Babovic, Nada
    JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (05) : 343 - 351
  • [45] Safety and Activity of Combined Radiotherapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) with Metastatic Melanoma
    Liniker, E.
    Kong, B.
    Menzies, A. M.
    Cooper, A.
    Ramanujam, S.
    Lo, S.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Wang, T. W.
    Carlino, M. S.
    Hong, A.
    Long, G. V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S664 - S664
  • [46] Is It Safe to Stop Anti-PD-1 Immunotherapy in Patients With Metastatic Melanoma Who Achieve a Complete Response?
    Davies, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1645 - +
  • [47] Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients.
    Brunot, Angelique
    Jeudy, Geraldine
    Tas, Mathieu
    Guillot, Bernard
    Kramkimel, Nora
    Mortier, Laurent
    Mansard, Sandrine
    Lebbe, Celeste
    Blom, Astrid
    Le Corre, Yannick
    Montaudie, Henri
    Prey, Sorilla
    Campillo-Gimenez, Boris
    Lesimple, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
    Afzal, Muhammad Zubair
    Mercado, Rima R.
    Shirai, Keisuke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [49] Impact of Anti-PD-1 Treatment in Patients with Metastatic Melanoma Brain Lesions Treated with Stereotactic Radiosurgery
    Goel, A.
    Kumar, R. J.
    Linam, J. M.
    Huang, A. J.
    Abendroth, R. E.
    Lee, J. W.
    Andrews, B.
    Leong, S.
    Leng, L. Z.
    Minor, D.
    Nosrati, M.
    Vosoughi, E.
    Miller, J.
    Kashani-Sabet, M.
    Kim, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E75 - E75
  • [50] PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma
    Parakh, Sagun
    Musafer, Ashan
    Paessler, Sabrina
    Witkowski, Tom
    Suen, Connie S. N. Li Wai
    Tutuka, Candani S. A.
    Carlino, Matteo S.
    Menzies, Alexander M.
    Scolyer, Richard A.
    Cebon, Jonathan
    Dobrovic, Alexander
    Long, Georgina V.
    Klein, Oliver
    Behren, Andreas
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345